Kohn, D. B., Shaw, K. L., Garabedian, E. K., Carbonaro-Sarracino, D. A., Moore, T. B., De Oliveira, S., … Gaspar, H. B. (2019). Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency. In JOURNAL OF CLINICAL IMMUNOLOGY (Vol. 39, pp. S42–S44). Atlanta, GA: SPRINGER/PLENUM PUBLISHERS.

Kohn, Donald B., Kit L. Shaw, Elizabeth K. Garabedian, Denise A. Carbonaro-Sarracino, Theodore B. Moore, Satiro De Oliveira, Gay M. Crooks, et al. “Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency.” In JOURNAL OF CLINICAL IMMUNOLOGY, 39:S42–44. SPRINGER/PLENUM PUBLISHERS, 2019.

Kohn DB, Shaw KL, Garabedian EK, Carbonaro-Sarracino DA, Moore TB, De Oliveira S, et al. Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency. In: JOURNAL OF CLINICAL IMMUNOLOGY. SPRINGER/PLENUM PUBLISHERS; 2019. p. S42–4.

Kohn, Donald B., et al. “Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency.” JOURNAL OF CLINICAL IMMUNOLOGY, vol. 39, SPRINGER/PLENUM PUBLISHERS, 2019, pp. S42–44.

Kohn DB, Shaw KL, Garabedian EK, Carbonaro-Sarracino DA, Moore TB, De Oliveira S, Crooks GM, Tse J, Shupien S, Terrazas D, Davila A, Icreverzi A, Yu A, Barman P, Coronel M, Fernandez BC, Zhang R, Hollis R, Uzowuru C, Ricketts H, Xu-Bayford J, Trevisan V, Arduini S, Lynn F, Kudari M, Spezzi A, Reeves L, Cornetta K, Sokolic R, Parrott R, Buckley R, Booth C, Candotti F, Malech HL, Thrasher AJ, Gaspar HB. Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency. JOURNAL OF CLINICAL IMMUNOLOGY. SPRINGER/PLENUM PUBLISHERS; 2019. p. S42–S44.